Creo Medical Group PLC Market Cap ($628.03K)
Market Cap & Net Worth: Creo Medical Group PLC (CREO)
Creo Medical Group PLC market cap. Creo Medical Group PLC (LSE:CREO) has a market capitalization of $628.03K (GBX5.16 Billion) as of November 8, 2026. Listed on the LSE stock exchange, this UK-based company holds position #30937 globally and #878 in its home market, demonstrating a -6.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Creo Medical Group PLC's stock price GBX10.63 by its total outstanding shares 485806647 (485.81 Million). Also see how efficiently does Creo Medical Group PLC generate cash for how efficiently the company converts equity into cash flow.
Creo Medical Group PLC Market Cap History (2016–2026)
Creo Medical Group PLC market cap history from 2016 to 2026. Data shows change from $4.82 Million to $628.03K (-18.42% CAGR). Check Creo Medical Group PLC share price for real-time trading data and today's change.
Index Memberships
Creo Medical Group PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$990.01 Million | 0.06% | #195 of 722 |
Weight: Creo Medical Group PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Creo Medical Group PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Creo Medical Group PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore CREO shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.10x
Creo Medical Group PLC's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.11x
Creo Medical Group PLC's market cap is 0.11 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $10.70 Million | $13.47K | -$15.91 Million | 794.08x | N/A |
| 2020 | $11.47 Million | $9.43 Million | -$20.32 Million | 1.22x | N/A |
| 2021 | $8.81 Million | $25.16 Million | -$24.59 Million | 0.35x | N/A |
| 2022 | $1.49 Million | $27.17 Million | -$26.94 Million | 0.05x | N/A |
| 2023 | $2.72 Million | $30.80 Million | -$21.70 Million | 0.09x | N/A |
| 2024 | $1.15 Million | $4.00 Million | -$28.70 Million | 0.29x | N/A |
| 2025 | $585.18K | $6.00 Million | $5.30 Million | 0.10x | 0.11x |
Competitor Companies of CREO by Market Capitalization
Companies near Creo Medical Group PLC in the global market cap rankings as of November 8, 2026. Also see CREO asset base for a full breakdown of the balance sheet.
Key companies related to Creo Medical Group PLC by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Creo Medical Group PLC (2016–2026)
Market capitalization of Creo Medical Group PLC from 2016 to today. Between 2016 and today, Creo Medical Group PLC's market cap moved from $4.82 Million to $ 628.03K, with a yearly change of -18.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX628.03K | +7.32% |
| 2025 | GBX585.18K | -49.23% |
| 2024 | GBX1.15 Million | -57.61% |
| 2023 | GBX2.72 Million | +82.18% |
| 2022 | GBX1.49 Million | -83.05% |
| 2021 | GBX8.81 Million | -23.20% |
| 2020 | GBX11.47 Million | +7.18% |
| 2019 | GBX10.70 Million | -9.05% |
| 2018 | GBX11.76 Million | +186.33% |
| 2017 | GBX4.11 Million | -14.72% |
| 2016 | GBX4.82 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Creo Medical Group PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $628.03K USD |
| MoneyControl | $628.03K USD |
| MarketWatch | $628.03K USD |
| marketcap.company | $628.03K USD |
| Reuters | $628.03K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices del… Read more